Drug Profile
Research programme: immune therapeutics - Genetic Immunity
Alternative Names: ChlamyDerm; DermAll; HuPaDermLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Genetic Immunity
- Class Vaccines
- Mechanism of Action Immunostimulants; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chlamydial infections; Human papillomavirus infections; Hypersensitivity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Allergy in USA
- 16 Jul 2016 No recent reports of development identified for research development in Chlamydial-infections in USA
- 16 Jul 2016 No recent reports of development identified for research development in Human-papillomavirus-infections in USA